UiPath (PATH): Valuation Perspective Following Gartner Leadership and Strong Earnings Momentum

UiPath (NYSE:PATH) just landed a significant spot in the Gartner Magic Quadrant, being placed as a Leader in Intelligent Document Processing for the first time. For investors watching the automation space, this is more than another industry accolade. Being recognized alongside top technology players highlights UiPath’s edge in unlocking value from complex, unstructured data, which is a big deal for enterprises navigating AI adoption. This development has arrived as the company also reported higher quarterly revenue and a swing to net profit, giving fresh energy to the conversation around UiPath’s future trajectory.

Looking at the broader picture, the stock has seen some volatility this year, dropping nearly 3% over the past 12 months but bouncing back by over 10% in the past month as positive sentiment has started to build. The dual boost of new product leadership and improving financials has certainly helped, especially given UiPath’s noticeable earnings progress and a more optimistic market outlook. These recent movements mark a shift from a weak first half of the year, with momentum gathering pace amid ongoing enthusiasm for automation and AI.

With the stock’s recent uptick and increasing attention on whether UiPath’s technology can stay ahead, the big question is whether today’s price reflects genuine upside or if Wall Street is already factoring in the next phase of growth.

Advertisement

Most Popular Narrative: 11.3% Undervalued

UiPath is widely considered undervalued right now based on prevailing analyst expectations, with the most popular narrative pointing to significant upside potential versus its current share price.

*New product launches such as Agent Builder and Agentic Orchestration, along with strategic partnerships like those with Microsoft and Deloitte, are positioned to expand market opportunities. This could potentially increase earnings through higher-value deals.*

Want to discover what’s behind this bullish outlook? The narrative leans on bold projections for future revenue and profit margins, influenced by major shifts in UiPath’s business model. Curious how much growth the analysts are really factoring in, and what kind of future valuation multiple they expect? There is a surprising set of assumptions behind this fair value estimate.

Result: Fair Value of $13.30 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, shifting market conditions and delayed contract decisions could quickly dampen this outlook. This makes short-term revenue projections less certain.

Find out about the key risks to this UiPath narrative.

Another View: SWS DCF Model

While most analysts rely on future earnings projections and market sentiment, our DCF model offers a different angle. It also points to undervaluation, but from a cash flow perspective. Could the true value lie somewhere in between?

Look into how the SWS DCF model arrives at its fair value.

PATH Discounted Cash Flow as at Sep 2025
PATH Discounted Cash Flow as at Sep 2025

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out UiPath for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover undervalued stocks based on their cash flows. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Build Your Own UiPath Narrative

If you think there’s more to this story or want to dive into the numbers yourself, you can easily craft your own narrative in just minutes. Do it your way

A great starting point for your UiPath research is our analysis highlighting 4 key rewards and 1 important warning sign that could impact your investment decision.

Looking for More Investment Ideas?

Don’t let promising opportunities slip by when there’s a world of innovative companies out there. Use the Simply Wall Street Screener and find your next smart move today.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Kshitija Bhandaru

Kshitija Bhandaru

Kshitija (or Keisha) Bhandaru is an Equity Analyst at Simply Wall St and has over 6 years of experience in the finance industry and describes herself as a lifelong learner driven by her intellectual curiosity. She previously worked with Market Realist for 5 years as an Equity Analyst.

About NYSE:PATH

UiPath

Provides an automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally.

Very undervalued with flawless balance sheet.

Advertisement

Weekly Picks

CE
Ceazar
CNXU logo
Ceazar on Conexeu Sciences ·

This small biotech is developing technology that could potentially change how tissue is rebuilt

Fair Value:US$25.3458.4% undervalued
53 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
IN
Investingwilly
MA logo
Investingwilly on Mastercard ·

Mastercard: The Best Dividend Stock You're Ignoring

Fair Value:US$75034.9% undervalued
4 users have followed this narrative
0 users have commented on this narrative
3 users have liked this narrative
TR
tripledub
INTU logo
tripledub on Intuit ·

A Wonderful Business at a Not-So-Wonderful Price

Fair Value:US$56053.9% undervalued
44 users have followed this narrative
1 users have commented on this narrative
26 users have liked this narrative
TA
Talos
HYFT logo
Talos on MindWalk Holdings ·

The Asymmetric TechBio Play: MindWalk Holdings and the Valuation Disconnect

Fair Value:US$8.2782.0% undervalued
8 users have followed this narrative
0 users have commented on this narrative
4 users have liked this narrative

Updated Narratives

HA
HarishPK
DOX logo
HarishPK on Amdocs ·

Why Amdocs is a high conviction Buy for me?

Fair Value:US$82.0336.2% undervalued
2 users have followed this narrative
1 users have commented on this narrative
0 users have liked this narrative
DE
Delphic
SMR logo
Delphic on NuScale Power ·

NuScale is Postioned For Long-Term Growth

Fair Value:US$10089.1% undervalued
10 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
TR
WMT logo
Treasury_Raccoon_w0gg on Walmart ·

Walmart's 'Other' Segment Will Power New Growth Beyond Retail

Fair Value:US$154.5822.7% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

MA
martinarauz
NU logo
martinarauz on Nu Holdings ·

Investment Analysis (May 2026)

Fair Value:US$22.7444.6% undervalued
67 users have followed this narrative
0 users have commented on this narrative
16 users have liked this narrative
HA
HarishPK
ADBE logo
HarishPK on Adobe ·

Adobe: A Probabilistic Case for Undervaluation

Fair Value:US$319.9638.3% undervalued
61 users have followed this narrative
9 users have commented on this narrative
18 users have liked this narrative
HE
HedgeY
ASTS logo
HedgeY on AST SpaceMobile ·

AST SpaceMobile: The Boldest Direct-to-Cell Bet in Public Markets

Fair Value:US$17057.1% undervalued
51 users have followed this narrative
0 users have commented on this narrative
13 users have liked this narrative